NCT02172339View on ClinicalTrials.gov

The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

December 31, 1998

Conditions
Renal Insufficiency
Interventions
DRUG

Tiotropium, solution ampoules

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172339 - The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects | Biotech Hunter | Biotech Hunter